Adagio Medical, Inc. – Trademark Portfolio

Entity Type: 03

Adagio Medical, Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 9 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include VCLAS and ADAGIO. The owner is based in Laguna Hills, CA.

26051 Merit Circle, Suite 102

Laguna Hills, CA 92653

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Adagio Medical, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (9 filings)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (4 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does Adagio Medical, Inc. have?

Adagio Medical, Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending, 7 abandoned.

What trademark classes does Adagio Medical, Inc. file in?

Adagio Medical, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Adagio Medical, Inc.'s most well-known trademarks?

Adagio Medical, Inc.'s registered trademark portfolio includes well-known marks such as VCLAS and ADAGIO. These are among 3 currently registered trademarks in the portfolio.

What is Adagio Medical, Inc.'s trademark registration success rate?

Adagio Medical, Inc. has a 30% trademark registration rate, with 3 out of 10 resolved applications resulting in successful registration. Currently, 1 application is pending review.